Clinical Trials Browser

Phase 2/3 × Deglutition Disorders × Head & Neck × Clear all

NCT01279837 2012-01-05

Pharyngocise Dose Response Study

Phase 2/3 Completed

Deglutition Disorders, Head and Neck Neoplasms